当前位置: 首页 > 期刊 > 《中外女性健康.下半月》 > 2013年第6期
编号:12820622
替吉奥联合奥沙利铂治疗老年晚期大肠癌的临床观察(2)
http://www.100md.com 2013年6月1日 中外女性健康·下半月 2013年第6期
     [2]张彤,马晓,张蕊.替吉奥治疗老年或功能状态评分差晚期结直肠癌患者的疗效观察[J].中国全科医学,2013,3:305-307.

    [3]ROUGIER PH,PAILLOT B,LA PLANCHE A,et a1.5-fluorouracil continous intravenous infusion compared with bious administration stration:final results of a randomized trail inmetastatie colorectal cancer[J].Eur J Cancer,1997,33(11):1789-1793.

    [4]刘萍.替吉奥维持治疗晚期非小细胞肺癌临床疗效观察[J].中国全科医学,2013,9:1038-1040.

    [5]GIACCHETTI S,PERPOINT B,ZIGANI R,et a1.PhaseⅢmulticenter randomized trail of oxaliplatin added to chronomodulated fluorouracil-1eucovorin as first-line treatment of metastatic colorectal cancer[J].J Clin Oncol,2000,18(1):136—147.

    [6]孙燕,石元凯.临床肿瘤内科手册[M].5版.北京:人民卫生出版社,2007:504-505.

    [7] Berretta M ,Zanet E,Nasti G,et a1.Oxaliplatin- based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer(CRC)[J].Arch Gemntol Geriatr,2012,55(2):271.

    [8] Benavides M ,Pericay C,Valladares-Ayerbes M ,et a1. Oxaliplatin in combination with infusional 5-Fluomuracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer:A phase II study of the spanish cooperative group for the treatment of digestive tumors[J].Cin Colorectal Cancer,2012,11(3):200, 百拇医药(仰丽丽 文剑)
上一页1 2